Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency
Open Access
- 23 June 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (12), 2606-2610
- https://doi.org/10.1182/bloodadvances.2020001736
Abstract
3D organoid T-cell differentiation from a few hundred peripheral blood CD34+ cells was successfully achieved. 3D organoid T-cell differentiation could help physicians distinguish intrinsic from extrinsic defects underlying a clinical SCID phenotype.This publication has 10 references indexed in Scilit:
- Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopeniaBlood Advances, 2020
- Towards manufacturing of human organoidsBiotechnology Advances, 2020
- The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)Journal of Allergy and Clinical Immunology, 2018
- Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoidsNature Methods, 2017
- Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficienciesBlood, 2016
- Faculty Opinions recommendation of Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.Published by H1 Connect ,2015
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- Induction of T Cell Development from Hematopoietic Progenitor Cells by Delta-like-1 In VitroImmunity, 2002
- Introduction to Immunodeficiency ReviewsClinical and Experimental Immunology, 2000
- Purinogenic Immunodeficiency Diseases: Clinical Features and Molecular MechanismsAnnals of Internal Medicine, 1980